SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891092-03-001529
Filing Date
2003-07-14
Accepted
2003-07-14 15:39:56
Documents
5
Period of Report
2003-07-10
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e15169_8k.txt 8-K 6077
3 EXHIBIT 10.1 e15169ex10_1.txt EX-10.1 132868
4 EXHIBIT 10.2 e15169ex10_2.txt EX-10.2 174130
5 EXHIBIT 10.3 e15169ex10_3.txt EX-10.3 71333
6 EXHIBIT 10.4 e15169ex10_4.txt EX-10.4 69367
  Complete submission text file 0000891092-03-001529.txt   455864
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 03785391
SIC: 2836 Biological Products, (No Diagnostic Substances)